Intech Investment Management LLC Sells 69,371 Shares of Tenet Healthcare Corporation $THC

Intech Investment Management LLC cut its stake in Tenet Healthcare Corporation (NYSE:THC) by 54.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 59,152 shares of the company’s stock after selling 69,371 shares during the quarter. Intech Investment Management LLC owned approximately 0.07% of Tenet Healthcare worth $12,010,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of THC. William B. Walkup & Associates Inc. bought a new position in Tenet Healthcare in the 3rd quarter valued at about $32,000. Canada Pension Plan Investment Board acquired a new position in shares of Tenet Healthcare in the second quarter valued at approximately $35,000. Westside Investment Management Inc. lifted its holdings in Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after purchasing an additional 96 shares during the last quarter. Trust Co. of Vermont bought a new stake in Tenet Healthcare in the 3rd quarter valued at $41,000. Finally, True Wealth Design LLC increased its position in Tenet Healthcare by 238.2% during the 2nd quarter. True Wealth Design LLC now owns 257 shares of the company’s stock worth $45,000 after buying an additional 181 shares during the period. Institutional investors own 95.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on THC. Royal Bank Of Canada upped their price target on shares of Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a research note on Thursday, February 12th. Wall Street Zen lowered shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, February 21st. Truist Financial boosted their price target on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. Jefferies Financial Group increased their price target on Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and issued a $265.00 price objective on shares of Tenet Healthcare in a report on Monday, February 16th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $247.67.

Tenet Healthcare Stock Up 1.1%

NYSE THC opened at $239.73 on Friday. The business has a fifty day moving average price of $205.17 and a two-hundred day moving average price of $199.24. The stock has a market capitalization of $20.85 billion, a PE ratio of 15.48, a PEG ratio of 1.15 and a beta of 1.44. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $240.83. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. The company had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.Tenet Healthcare’s revenue was up 8.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Insider Buying and Selling at Tenet Healthcare

In related news, Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the sale, the director directly owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. The trade was a 7.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.81% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.